Kelly Handley

Value of Mismatch Repair, <i>KRAS</i> , and <i>BRAF</i> Mutations in Predicting Recurrence and Benefits From Chemotherapy in Colorectal Cancer

Gordon Hutchins, Katie Southward, Kelly Handley et al. · Journal of Clinical Oncology · 2011 · 675 citations · Full text

aTTom: Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years in 6,953 women with early breast cancer.

Richard Gray, Daniel Rea, Kelly Handley et al. · Journal of Clinical Oncology · 2013 · 446 citations

Breast Oncology, Cancer Management, Epidemiology Of Cancer +17

Preoperative Chemotherapy for Operable Colon Cancer: Mature Results of an International Randomized Controlled Trial

Dion Morton, Laura Magill, Kelly Handley et al. · Journal of Clinical Oncology · 2023 · 387 citations · Full text

Validation Study of a Quantitative Multigene Reverse Transcriptase–Polymerase Chain Reaction Assay for Assessment of Recurrence Risk in Patients With Stage II Colon Cancer

Richard Gray, Philip Quirke, Kelly Handley et al. · Journal of Clinical Oncology · 2011 · 369 citations · Full text

<scp>HER2</scp> overexpression and amplification as a potential therapeutic target in colorectal cancer: analysis of 3256 patients enrolled in the <scp>QUASAR</scp>, <scp>FOCUS</scp> and <scp>PICCOLO</scp> colorectal cancer trials

Susan D. Richman, Katie Southward, Philip Chambers et al. · The Journal of Pathology · 2015 · 231 citations · Full text